CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Clark George C. VP, Chief Accounting Officer | Option exercise · Restricted Share Unit Award | −2,500 | 5,000 | ||
| 2026-01-05 | Car Bruce Chief Scientific Officer | Option exercise | +4,750 | 10,096 | ||
| 2026-01-05 | Car Bruce Chief Scientific Officer | Shares withheld for taxes | −2,381 | $9.93 | $24K | 7,715 |
| 2026-01-05 | Car Bruce Chief Scientific Officer | Option exercise · Restricted Share Unit Award | −4,750 | 9,500 | ||
| 2026-01-05 | Coric Vlad Chief Executive Officer | Option exercise | +14,250 | 1,811,398 | ||
| 2026-01-05 | Coric Vlad Chief Executive Officer | Shares withheld for taxes | −7,430 | $9.93 | $74K | 1,803,968 |
| 2026-01-05 | Coric Vlad Chief Executive Officer | Option exercise · Restricted Share Unit Award | −14,250 | 28,500 | ||
| 2026-01-05 | Gentile Kimberly SVP, Clinical Operations | Option exercise | +3,750 | 101,513 | ||
| 2026-01-05 | Gentile Kimberly SVP, Clinical Operations | Shares withheld for taxes | −1,956 | $9.93 | $19K | 99,557 |
| 2026-01-05 | Gentile Kimberly SVP, Clinical Operations | Option exercise · Restricted Share Unit Award | −3,750 | 7,500 | ||
| 2025-11-17 | Clark George C. VP, Chief Accounting Officer | Purchase | +17,000 | $8.52 | $145K | 20,000 |
| 2025-11-13 | Bailey Gregory Director | Purchase | +400,000 | $7.50 | $3.0M | 2,020,071 |
| 2025-11-13 | Coric Vlad Chief Executive Officer | Purchase | +333,333 | $7.50 | $2.5M | 1,195,275 |
| 2025-11-13 | Coric Vlad Chief Executive Officer | Purchase | +333,333 | $7.50 | $2.5M | 740,546 |
| 2025-11-13 | CHILDS JOHN W Director | Purchase | +3,333,333 | $7.50 | $25.0M | 5,653,904 |
| 2025-05-05 | Antonijevic Irina Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-05-05 | Heffernan Michael Thomas Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-05-05 | Bailey Gregory Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-05-05 | Mehta Kishan Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 | ||
| 2025-05-05 | GREGORY JULIA P Director | Grant or award · Stock Options (Right to buy) | +31,716 | 31,716 |
Page 2 of 18 · 355 trades